USPTO 2015–2025 USPTO PatentsView US Corporation

LanzaTech New Zealand Limited

USPTO PatentsView assignee record - 52 granted patents across 18 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Lanzatech ranks #6,455 of 49,997 tracked US assignees by granted-patent volume, with 52 patents across 18 technology areas.

#6,455
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.4/100)
15.4
avg claims per patent
-76%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6455 · US Corporation #6,455 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 52 grants
  • UPPER-Q #6,455/49,997
  • PHOTO-FINISH Kala Pharmaceuticals
  • CPC-FOCUS C12P · 18 areas
  • INNOV-THIN 38.4/100
  • CLAIMS-RICH 15.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -76% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kala Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lanzatech’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Lanzatech

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Lanzatech's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Lanzatech?

Each dot is one of Lanzatech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lanzatech’s own 15.4 claims/patent is ABOVE the 10.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lanzatech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 51.952.052.05252.052.052.1 010203040 Granted patents (volume) Avg claims / patent Kyowa Hakko BIO Co., Ltd. - 52, 10Kyowa Hakko BIOKyushu University - 52, 12.1Kyushu UniversityKala Pharmaceuticals, Inc. - 52, 22.88Kala Pharmaceutic…King Furniture Australia Pty Ltd. - 52, 2.27King Furniture Au…Limagrain Europe S.A. - 52, 31.15Limagrain EuropeLumson S.p.A. - 52, 7.1Lumson S p AM31 Technology Corporation - 52, 18.12M31 TechnologyMAN Diesel & Turbo SE - 52, 10.33MAN Diesel & Turb…LanzaTech New Zealand Limited - 52, 15.4Lanzatech New Zea…
Lanzatech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lanzatech's grants concentrate

LanzaTech New Zealand Limited is a focused PatentsView assignee: 18 CPC subclasses with 86.5% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2016 (11 grants) versus a trough of 1 in 2022. By volume, Lanzatech sits between Kyowa Hakko BIO Co., Ltd. and MAN Diesel & Turbo SE.

Lanzatech's three-year grant acceleration

LanzaTech New Zealand Limited shows 1 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at LanzaTech's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows LanzaTech holds 52 patents at rank #6,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near LanzaTech

By rank, the assignees closest to #6,455 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in LanzaTech's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for LanzaTech, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), LanzaTech ranks #28 of 1,268 assignees by patent count in that subclass.

Lanzatech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022 1
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
LanzaTech New Zealand Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 7.7%
2016 11 21.2%
2017 11 21.2%
2018 8 15.4%
2019 8 15.4%
2020 5 9.6%
2021 4 7.7%
2022 1 1.9%

Which technologies does LanzaTech New Zealand Limited patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

LanzaTech New Zealand Limited's patent record in context - here's where to go next.

  • LanzaTech New Zealand Limited's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 86.5% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #6,455 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare LanzaTech New Zealand Limited against Kyowa Hakko BIO Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.